This isn’t a supply problem. It’s a distribution problem. The physicians exist. The system just isn’t getting them where they need to be. The post Everyone’s Betting on AI to Solve the Physician Shortage —They’re Solving the Wrong Problem appeared first on MedCity News.
A paper by Qato et al. (2024) quantifies the degree of of pharmacy benefit manager (PBM) market concentration. Across all payer types, the PBM market was highly concentrated, with an HHI [Herfindahl Hirschman Index (HHI)] of 1972…the HHI was lowest in commercial insurance (1940), with 90 PBM participants, and highest in Medicare Part D (2399),…
By MIKE MAGEE Funny think about that Project 2025’s “Mandate for Leadership.” Trump declared in this week’s debate, “I know nothing about it.” But in addition to the vast majority of authors and editors of the document having served in the prior Trump administration, the former President’s name is mentioned in the 887 page document…
[Sponsored] A webinar sponsored by Verato and scheduled for June 17 from 1 pm to 2 pm ET will explore how a unified identity strategy, spanning patients, providers, and emerging solutions enabling accurate attribution, strengthens interoperability, and ultimately drives VBC success. Register today! The post The Identity Gap Undermining Value-Based Care appeared first on MedCity News.
AllRock Bio’s drug is a small molecule pan-ROCK inhibitor ready for Phase 2 testing in pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease. The startup is led by the management team that steered CinCor Pharma to a $1.3 billion acquisition by AstraZeneca. The post With Drug Picked Up From Sanofi, Startup AllRock Takes…
According to the Washington Post, at least 390,000 students were exposed to a school shooting (exposure is defined as students attending a school at which a shooting occurred during the current school year) since the 1999 Columbine shooting. This brief analyzes the rate of student exposure to school shootings over time at the national and…
FDA approval for Eli Lilly’s oral GLP-1 drug, Foundayo, comes about three months after Novo Nordisk launched its Wegovy pill. While clinical trial results for both daily pills showed comparable weight reduction, Lilly’s pill offers patients a slight dosing advantage. The post Eli Lilly Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to…
Los incendios forestales que se propagan rápidamente y han transformado gran parte del condado de Los Ángeles en un infierno en llamas no solo están alterando las vidas de decenas de miles de residentes y dueños de negocios. También están poniendo a prueba a los hospitales, clínicas de salud, socorristas y hogares de adultos mayores…
Amgen’s experimental obesity drug, MariTide, led to an average 20% reduction in weight in a Phase 2 clinical trial. While investors hoped for greater weight loss, some analysts say less burdensome monthly dosing of MariTide could make it competitive against weekly injectable weight drugs Zepbound and Wegovy. The post Weight Loss With Amgen Drug in…
May 28 Jackie Fortiér [FOR-tee-ay] reads this week’s news: Suicide prevention experts argue that improving Americans’ financial well-being could save lives. Plus, the Trump administration proposes looser artificial intelligence safeguards to speed innovation in healthcare. The KFF Health News Minute is available every Thursday via direct download or the RSS feed. KFF Health News is a…